Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

INSYS Therapeutics Inc (NASDAQ:INSY)

5.05
Delayed Data
As of 1:00pm ET
 -0.15 / -2.88%
Today’s Change
4.10
Today|||52-Week Range
15.02
-45.11%
Year-to-Date
9 Stocks Arnold Schneider Keeps Buying
11:43am / GuruFocus News - Paid Partner Content
 

Today’s Trading

Previous close5.20
Today’s open5.28
Day’s range5.05 - 5.29
Volume514,915
Average volume (3 months)677,339
Market cap$381.2M
Dividend yield--
Data as of 1:00pm ET, 11/24/2017

Growth & Valuation

Earnings growth (last year)-87.01%
Earnings growth (this year)-210.53%
Earnings growth (next 5 years)+28.00%
Revenue growth (last year)-26.76%
P/E ratioNM
Price/Sales2.82
Price/Book1.39

Competitors

 Today’s
change
Today’s
% change
ALDRAlder Biopharmaceuti...+0.25+2.44%
SGYPSynergy Pharmaceutic...0.000.00%
LCILannett Company Inc+1.95+7.63%
VSARVersartis Inc+0.07+4.05%
Data as of 1:01pm ET, 11/24/2017

Financials

Next reporting dateMarch 6, 2018
EPS forecast (this quarter)-$0.15
Annual revenue (last year)$242.3M
Annual profit (last year)$7.6M
Net profit margin3.13%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Saeed Motahari
Chief Financial Officer
Andrew G. Long
Corporate headquarters
Chandler, Arizona

Forecasts